Carnegie Investment Counsel’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,361
Closed -$278K 486
2023
Q3
$278K Sell
7,361
-2,139
-23% -$91.1K 0.01% 427
2023
Q2
$433K Buy
9,500
+510
+6% +$22.2K 0.02% 372
2023
Q1
$365K Buy
8,990
+237
+3% +$10K 0.01% 401
2022
Q4
$446K Buy
8,753
+254
+3% +$13.6K 0.02% 375
2022
Q3
$458K Buy
8,499
+116
+1% +$6.98K 0.02% 345
2022
Q2
$538K Buy
8,383
+491
+6% +$35.6K 0.02% 325
2022
Q1
$612K Buy
7,892
+92
+1% +$7.7K 0.02% 322
2021
Q4
$670K Buy
7,800
+589
+8% +$47.4K 0.02% 322
2021
Q3
$580K Hold
7,211
0.02% 300
2021
Q2
$580K Buy
7,211
+500
+7% +$41.9K 0.02% 310
2021
Q1
$566K Hold
6,711
0.02% 303
2020
Q4
$538K Sell
6,711
-810
-11% -$64.2K 0.02% 289
2020
Q3
$605K Hold
7,521
0.03% 261
2020
Q2
$648K Hold
7,521
0.04% 248
2020
Q1
$611K Sell
7,521
-95
-1% -$8.2K 0.04% 245
2019
Q4
$637K Hold
7,616
0.04% 271
2019
Q3
$666K Hold
7,616
0.04% 251
2019
Q2
$624K Buy
7,616
+500
+7% +$38.8K 0.04% 271
2019
Q1
$579K Buy
7,116
+900
+14% +$65.5K 0.04% 273
2018
Q4
$409K Buy
6,216
+3,030
+95% +$204K 0.04% 278
2018
Q3
$212K Sell
3,186
-1,868
-37% -$139K 0.02% 325
2018
Q2
$357K Buy
5,054
+93
+2% +$6.55K 0.03% 298
2018
Q1
$350K Hold
4,961
0.03% 287
2017
Q4
$325K Buy
4,961
+44
+0.9% +$2.83K 0.03% 316
2017
Q3
$314K Hold
4,917
0.04% 291
2017
Q2
$296K Hold
4,917
0.04% 294
2017
Q1
$276K Sell
4,917
-3,000
-38% -$148K 0.03% 294
2016
Q4
$355K Buy
7,917
+2,821
+55% +$130K 0.05% 249
2016
Q3
$241K Buy
5,096
+1
+0% +$47 0.03% 281
2016
Q2
$245K Buy
+5,095
New +$223K 0.03% 283

Other funds holding BAX

Carnegie Investment Counsel's BAX Position: Q4 2023 in Review

Carnegie Investment Counsel sold out of Baxter International (BAX) in Q4 2023, closing a stake of 7,361 shares — an estimated $278K sold.

Carnegie Investment Counsel first reported a position in BAX in Q2 2016 and held it in 30 quarters. The position peaked at $670K in Q4 2021. 912 funds tracked by Wall St. Rank hold BAX as of Q4 2023.

  • Carnegie Investment Counsel reported no remaining Baxter International position as of Q4 2023 after selling out during the quarter.
  • Carnegie Investment Counsel sold 7,361 Baxter International shares in Q4 2023, an estimated $278K.
  • Carnegie Investment Counsel first reported a position in Baxter International in Q2 2016 and held it in 30 quarters.
  • Carnegie Investment Counsel's Baxter International position peaked at $670K in Q4 2021.
  • 912 funds tracked by Wall St. Rank held Baxter International as of Q4 2023.

Based on Carnegie Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.